Idiopathic (primary) achalasia

Orphanet Journal of Rare Diseases

Volumn 2, Issue 1, 2007, Pages

  Farrokhi, Farnoosh ^a   Vaezi, Michael F ^a  

^a VANDERBILT UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANIMAL; DYSPHAGIA; ESOPHAGUS ACHALASIA; ESOPHAGUS FUNCTION DISORDER; GASTROESOPHAGEAL REFLUX; HUMAN; REVIEW;

ANIMALS; DEGLUTITION DISORDERS; ESOPHAGEAL ACHALASIA; ESOPHAGEAL MOTILITY DISORDERS; GASTROESOPHAGEAL REFLUX; HUMANS;

EID: 35348999522     PISSN: None     EISSN: 17501172     Source Type: Journal    
DOI: 10.1186/1750-1172-2-38     Document Type: Article

References (83)

1. Vaezi MF: Achalasia: diagnosis and management. Semin Gastrointest Dis 1999, 10:103-112.
2. Vaezi MF, Richter JE, Wilcox CM, Schroeder PL, Birgisson S, Slaughter RL, Koehler RE, Baker ME: Botulinum toxin versus pneumatic dilatation in the treatment of achalasia: a randomised trial. Gut 1999, 44:231-239.
3. Park W, Vaezi MF: Etiology and pathogenesis of achalasia: the current understanding. Am J Gastroenterol 2005, 100:1404-1414.
4. Mikaeli J, Farrokhi F, Bishehsari F, Mahdavinia M, Malekzadeh R: Gender effect on clinical features of achalasia: a prospective study. BMC Gastroenterol 2006, 1 (6):12-12.
5. Vela MF, Vaezi MF: Cost-assessment of alternative management strategies for achalasia. Expert Opin Pbarmacother 2003, 4:2019-2025.
6. Birgisson S, Richter JE: Achalasia: what's new in diagnosis and treatment? Dig Dis 1997, 15(Suppl 1):1-27.
7. Prakash C, Clouse RE: Esophageal motor disorders. Curr Opin Gastroenterol 1999, 15:339.
8. Achkar E: Achalasia. Gostroenterotogist 1995, 3:273-288.
9. Richter JE: Modern management of achalasia. Curr Treat Options Gastroenterol 2005, 8:275-283.
10. Annese V, Bassotti G: Non-surgical treatment of esophageal achalasia. World J Gastroenterol 2006, 12:5763-5766.
11. Guardino JM, Vela MF, Connor JT, Richter JE: Pneumatic dilation for the treatment of achalasia in untreated patients and patients with failed Heller myotomy. J Clin Gastroenterol 2004, 38:855-860.
12. Vaezi MF, Baker ME, Achkar E, RichterJE: Timed barium oesophagram: better predictor of long term success after pneumatic dilation in achalasia than symptom assessment. Gut 2002, 50:765-770.
13. Vaezi MF, Richter JE: Current therapies for achalasia: comparison and efficacy. J Clin Gastroenterol 1998, 27:21-35.
14. Clouse RE, Abramson BK, Todorczuk JR: Achalasia in the elderly. Effects of aging on clinical presentation and outcome. Dig Dis Sci 1991, 36:225-228.
15. d'Alteroche L, Oung C, Fourquet F, Picon L, Lagasse JP, Metman EH: Evolution of clinical and radiological features at diagnosis of achalasia during a 19-year period in central France. Eur J Gastroenterol Hepatol 2001, 13:121-126.
16. Rakita S, Bloomston M, Villadolid D, Thometz D, Boe B, Rosemurgy A: Age affects presenting symptoms of achalasia and outcomes after myotomy. Am Surg 2005, 71:424-429.
17. Spechler SJ, Souza RF, Rosenberg SJ, Ruben RA, Goyal RK: Heartburn in patients with achalasia. Gut 1995, 37:305-308.
18. Sandler RS, Nyren O, Ekbom A, Eisen GM, Yuen J, Josefsson S: The risk of esophageal cancer in patients with achalasia. A population-based study. JAMA 1995, 274:1359-1362.
19. Mearin F, Mourelle M, Guarner F, Salas A, Riveros-Moreno V, Moneada S, Malagelada JR: Patients with achalasia lack nitric oxide synthase in the gastro-oesophageal junction. Eur J Clin Invest 1993, 23:724-728.
20. CASSELLA RR, BROWN AL Jr., SAYRE GP, ELLIS FH Jr.: ACHALASIA OF THE ESOPHAGUS: PATHOLOGIC AND ETIOLOGIC CONSIDERATIONS. Ann Surg 1964, 160():474-487.
21. Higgs B, Kerr FW, ELLIS FH Jr.: The experimental production of esophageal achalasia by electrolytic lesions in the medulla. J Thorac Cardiavasc Surg 1965, 50:613-625.
22. Atkinson M, Ogilvie AL, Robertson CS, Smart HL: Vagal function in achalasia of the cardia. Q J Med 1987, 63:297-303.
23. Eckardt VF, Krause J, Bolle D: Gastrointestinal transit and gastric acid secretion in patients with achalasia. Dig Dis Sci 1989, 34:665-671.
24. Khajanchee YS, VanAndel R, Jobe BA, Barra MJ, Hansen PD, Swanstrom LL: Electrical stimulation of the vagus nerve restores motility in an animal model of achalasia. J Gastrointest Surg 2003, 7:843-849.
25. Holloway RH, Dodds WJ, Helm JF, Hogan WJ, Dent J, Arndorfer RC: Integrity of cholinergic innervation to the lower esophageal sphincter in achalasia. Gastroenterology 1986, 90:924-929.
26. Greaves RR, Mulcahy HE, Patchett SE, Gorard DA, Fairclough PD, Alstead EM, Farthing MJ: Early experience with intrasphincteric botulinum toxin in the treatment of achalasia. Aliment Pharmacol Ther 1999, 13:1221-1225.
27. Dodds WJ, Dent J, Hogan WJ, Patel GK, Toouli J, Arndorfer RC: Paradoxical lower esophageal sphincter contraction induced by cholecystokinin-octapeptide in patients with achalasia. Gastroenterology 1981, 80:327-333.
28. Goldblum JR, Whyte RI, Orringer MB, Appelman HD: Achalasia. A morphologic study of 42 resected specimens. Am J Surg Pathol 1994, 18:327-337.
29. Goldblum JR, Rice TW, Richter JE: Histopathologic features in esophagomyotomy specimens from patients with achalasia. Gastroenterology 1996, 111:648-654.
30. Frieling T, Berges W, Borchard F, Lubke HJ, Enck P, Wienbeck M: Family occurrence of achalasia and diffuse spasm of the oesophagus. Gut 1988, 29:1595-1602.
31. Stein DT, Knauer CM: Achalasia in monozygotic twins. Dig Dis Sci 1982, 27:636-640.
32. Annese V, Napolitano G, Minervini MM, Perri F, Ciavarella G, Di Giorgio G, Andriulli A: Family occurrence of achalasia. J Clin Gastroenterol 1995, 20:329-330.
33. Bosher LP, Shaw A: Achalasia in siblings. Clinical and genetic aspects. Am J Dis Child 1981, 135:709-710.
34. Jones DB, Mayberry JF, Rhodes J, Munro J: Preliminary report of an association between measles virus and achalasia. J Clin Pathol 1983, 36:655-657.
35. Robertson CS, Martin BA, Atkinson M: Varicella-zoster virus DNA in the oesophageal myenteric plexus in achalasia. Gut 1993, 34:299-302.
36. Niwamoto H, Okamoto E, Fujimoto J, Takeuchi M, Furuyama J, Yamamoto Y: Are human herpes viruses or measles virus associated with esophageal achalasia? Dig Dis Sci 1995, 40:859-864.
37. Birgisson S, Galinski MS, Goldblum JR, Rice TW, Richter JE: Achalasia is not associated with measles or known herpes and human papilloma viruses. Dig Dis Sci 1997, 42:300-306.
38. Storch WB, Eckardt VF, Wienbeck M, Eberl T, Auer PG, Hecker A, Junginger T, Bosseckert H: Autoantibodies to Auerbach's plexus in achalasia. Cell Mol Biol (Noisy -le-grand) 1995, 41:1033-1038.
39. Verne GN, Sallustio JE, Eaker EY: Anti-myenteric neuronal antibodies in patients with achalasia. A prospective study. Dig Dis Sci 1997, 42:307-313.
40. Moses PL, Ellis LM, Anees MR, Ho W, Rothstein RI, Meddings JB, Sharkey KA, Mawe GM: Antineuronal antibodies in idiopathic achalasia and gastro-oesophageal reflux disease. Gut 2003, 52:629-636.
41. Raymond L, Lach B, Shamji FM: Inflammatory aetiology of primary oesophageal achalasia: an immunohistochemical and ultrastructural study of Auerbach's plexus. Histopathology 1999, 35:445-453.
42. Clark SB, Rice TW, Tubbs RR, Richter JE, Goldblum JR: The nature of the myenteric infiltrate in achalasia: an immunohistochemical analysis. Am J Surg Pathol 2000, 24:1153-1158.
43. Wong RK, Maydonovitch CL, Metz SJ, Baker JR Jr.: Significant DQwI association in achalasia. Dig Dis Sci 1989, 34:349-352.
44. De Ia Concha EG, Fernandez-Arquero M, Mendoza JL, Conejero L, Figueredo MA, Perez S, Diaz-Rubio M, Ruiz L: Contribution of HLA class II genes to susceptibility in achalasia. Tissue Antigens 1998, 52:381-384.
45. Verne GN, Hahn AB, Pineau BC, Hoffman BJ, Wojciechowski BW, Wu WC: Association of HLA-DR and -DQ alleles with idiopathic achalasia. Gastroenterology 1999, 117:26-31.
46. Ruiz-de-Leon A, Mendoza J, Sevilla-Mantilla C, Fernandez AM, Perezde-la-Serna J, Gonzalez VA, Rey E, Figueredo A, Diaz-Rubio M, De la Concha EG: Myenteric antiplexus antibodies and class II HLA in achalasia. Dig Dis Sci 2002, 47:15-19.
47. Vantrappen G, VANGOIDSENHOVEN GE, VERBEKE S, VANDENBERGHE G, VANDERBROUCKE J: MANOMETRIC STUDIES IN ACHALASIA OF THE CARDIA, BEFORE AND AFTER PNEUMATIC DILATIONS. Gastroenterology 1963, 45:317-325.
48. Camacho-Lobato L, Katz PO, Eveland J, Vela M, Castell DO: Vigorous achalasia: original description requires minor change. J Clin Gastroenterol 2001, 33:375-377.
49. Vantrappen G, Hellemans J, Deloof W, Valembois P, Vandenbroucke J: Treatment of achalasia with pneumatic dilatations. Gut 1971, 12:268-275.
50. de Oliveira JM, Birgisson S, Doinoff C, Einstein D, Herts B, Davros W, Obuchowski N, Koehler RE, Richter J, Baker ME: Timed barium swallow: a simple technique for evaluating esophageal emptying in patients with achalasia. AJR Am J Roentgenol 1997, 169:473-479.
51. Pehlivanov N, Pasricha PJ: Achalasia: botox, dilatation or laparoscopic surgery in 2006. Neurogastroenterol Motil 2006, 18:799-804.
52. Gelfond M, Rozen P, Gilat T: Isosorbide dinitrate and nifedipine treatment of achalasia: a clinical, manometric and radionuclide evaluation. Gastroenterology 1982, 83:963-969.
53. Bortolotti M, Coccia G, Brunelli F, Sarti P, Mazza M, Bagnato F, Barbara L: Isosorbide dinitrate or nifedipine: which is preferable in the medical therapy of achalasia? Ital J Gastroenterol 1994, 26:379-382.
54. Pasricha PJ, Ravich WJ, Hendrix TR, Sostre S, Jones B, Kalloo AN: Treatment of achalasia with intrasphincteric injection of botulinum toxin. A pilot trial. Ann Intern Med 1994, 121:590-591.
55. Pasricha PJ, Ravich WJ, Hendrix TR, Sostre S, Jones B, Kalloo AN: Intrasphincteric botulinum toxin for the treatment of achalasia. N Engl J Med 1995, 332:774-778.
56. Fishman VM, Parkman HP, Schiano TD, Hills C, Dabezies MA, Cohen S, Fisher RS, Miller LS: Symptomatic improvement in achalasia after botulinum toxin injection of the lower esophageal sphincter. Am J Gastroenterol 1996, 91:1724-1730.
57. Annese V, Bassotti G, Coccia G, Dinelli M, D'Onofrio V, Gatto G, Leandro G, Repici A, Testoni PA, Andriulli A: A multicentre randomised study of intrasphincteric botulinum toxin in patients with oesophageal achalasia. GISMAD Achalasia Study Group. Gut 2000, 46:597-600.
58. Pasricha PJ, Rai R, Ravich WJ, Hendrix TR, Kalloo AN: Botulinum toxin for achalasia: long-term outcome and predictors of response. Gastroenterology 1996, 110:1410-1415.
59. Eckardt VF, Aignherr C, Bernhard G: Predictors of outcome in patients with achalasia treated by pneumatic dilation. Gastroenterology 1992, 103:1732-1738.
60. Eckardt VF, Gockel I, Bernhard G: Pneumatic dilation for achalasia: late results of a prospective follow up investigation. Gut 2004, 53:629-633.
61. Torbey CF, Achkar E, Rice TW, Baker M, Richter JE: Long-term outcome of achalasia treatment: the need for closer followup. J Clin Gastroenterol 1999, 28:125-130.
62. Karamanolis G, Sgouros S, Karatzias G, Papadopoulou E, Vasiliadis K, Stefanidis G, Mantides A: Long-term outcome of pneumatic dilation in the treatment of achalasia. Am J Gastroenterol 2005, 100:270-274.
63. Farhoomand K, Connor JT, Richter JE, Achkar E, Vaezi MF: Predictors of outcome of pneumatic dilation in achalasia. Clin Gastroenterol Hepatol 2004, 2:389-394.
64. Vela MF, Richter JE, Khandwala F, Blackstone EH, Wachsberger D, Baker ME, Rice TW: The long-term efficacy of pneumatic dilatation and Heller myotomy for the treatment of achalasia. Clin Gastroenterol Hepatol 2006, 4:580-587.
65. Marshall JB, Bodnarchuk G, Singh A: Supine and upright radionuclide esophageal transit before and after treatment for achalasia. Clin Nuel Med 1994, 19:683-686.
66. Kim CH, Cameron AJ, Hsu JJ, Talley NJ, Trastek VF, Pairolero PC, O'Connor MK, Colwell LJ, Zinsmeister AR: Achalasia: prospective evaluation of relationship between lower esophageal sphincter pressure, esophageal transit, and esophageal diameter and symptoms in response to pneumatic dilation. Mayo Clin Proc 1993, 68:1067-1073.
67. Gross R, Johnson LF, Kaminski RJ: Esophageal emptying in achalasia quantitated by a radioisotope technique. Dig Dis Sci 1979, 24:945-949.
68. Vaezi MF, Baker ME, Richter JE: Assessment of esophageal emptying post-pneumatic dilation: use of the timed barium esophagram. Am J Gastroenterol 1999, 94:1802-1807.
69. Vaezi MF: Quantitative methods to determine efficacy of treatment in achalasia. Gastrointest Endose Clin N Am 2001, 11:409-4ix.
70. Bonavina L: Minimally invasive surgery for esophageal achalasia. World J Gastroenterol 2006, 12:5921-5925.
71. Annese V, Basciani M, Perri F, Lombardi G, Frusciante V, Simone P, Andriulli A, Vantrappen G: Controlled trial of botulinum toxin injection versus placebo and pneumatic dilation in achalasia. Gastroenterology 1996, 111:1418-1424.
72. Mikaeli J, Fazel A, Montazeri G, Yaghoobi M, Malekzadeh R: Randomized controlled trial comparing botulinum toxin injection to pneumatic dilatation for the treatment of achalasia. Aliment Pharmacol Ther 2001, 15:1389-1396.
73. O'Connor JB, Singer ME, Imperiale TF, Vaezi MF, Richter JE: The cost-effectiveness of treatment strategies for achalasia. Dig Dis Sci 2002, 47:1516-1525.
74. Gockel I, Junginger T, Bernhard G, Eckardt VF: Heller myotomy for failed pneumatic dilation in achalasia: how effective is it? Ann Surg 2004, 239:371-377.
75. Gordon JM, Eaker EY: Prospective study of esophageal botulinum toxin injection in high-risk achalasia patients. Am J Gastroenterol 1997, 92:1812-1817.
76. Martinek J, Siroky M, Plottova Z, Eures J, Hep A, Spicak J: Treatment of patients with achalasia with botulinum toxin: a multicenter prospective cohort study. Dis Esophagus 2003, 16:204-209.
77. Zaninotto G, Annese V, Costantini M, Del Genio A, Costantino M, Epifani M, Gatto G, D'Onofrio V, Benini L, Contini S, Molena D, Battaglia G, Tardio B, Andriulli A, Ancona E: Randomized controlled trial of botulinum toxin versus laparoscopic heller myotomy for esophageal achalasia. Ann Surg 2004, 239:364-370.
78. Bessell JR, Lally CJ, Schloithe A, Jamieson GG, Devitt PG, Watson DI: Laparoscopic cardiomyotomy for achalasia: long-term outcomes. ANZ J Surg 2006, 76:558-562.
79. Dang Y, Mercer D: Treatment of esophageal achalasia with Heller myotomy: retrospective evaluation of patient satisfaction and disease-specific quality of life. Can J Surg 2006, 49:267-271.
80. Raiser F, Perdikis G, Hinder RA, Swanstrom LL, Filipi CJ, McBride PJ, Katada N, Neary PJ: Heller myotomy via minimal-access surgery- An evaluation of antireflux procedures. Arch Surg 1996, 131:593-597.
81. Hunt DR, Wills VL: Laparoscopic Heller myotomy for achalasia. Aust N Z J Surg 2000, 70:582-586.
82. Frantzides CT, Moore RE, Carlson MA, Madan AK, Zografakis JG, Keshavarzian A, Smith C: Minimally invasive surgery for achalasia: a 10-year experience. J Gastrointest Surg 2004, 8:18-23.
83. Zaninotto G, Costantini M, Molena D, Buin F, Carta A, Nicoletti L, Ancona E: Treatment of esophageal achalasia with laparoscopic Heller myotomy and Dor partial anterior fundoplication: prospective evaluation of 100 consecutive patients. J Gastrointest Surg 2000, 4:282-289.